Engineering 101

How AI Can Even Assist With Fetal Alcohol Spectrum Disorder

New AI Tool Can Screen for Fetal Alcohol Spectrum Disorder

0

Between 1% and 5% of children in the U.S. and western European companies could have Fetal Alcohol Spectrum Disorder (FASD), according to some studies. A new tool developed by scientists at the University of Southern California (USC), Queen’s University (Ontario) and Duke University use computer vision, machine learning, and artificial intelligence to screen for FASD in low-resource environments.

The tool uses a camera and computer vision to record patterns in children’s eye movements as they watch multiple one-minute videos or look towards/away from a target. The tool then identifies patterns that contrast to recorded eye movements by other children who watched the same videos or targets. The eye movements outside the norm were flagged by the researchers as children who might be at risk for having FASD and need more formal diagnoses by healthcare practitioners.

The technique was described in a study “Detection of Children/Youth With Fetal Alcohol Spectrum Disorder Through Eye Movement, Psychometric, and Neuroimaging Data,” by Chen Zhang, Angelina Paolozza, Po-He Tseng, James N. Reynolds, Douglas P. Munoz and Laurent Itti.

According to the paper’s corresponding author, Laurent Itti, a professor of computer science, psychology and neuroscience at USC, FASD is still quite difficult to diagnose. A professional diagnosis can take a long time, with the current work-up taking as much as an entire day.

This computer vision tool is not intended to replace a full diagnosis by professionals. But it can provide important feedback so that parents can ensure that their children are seen by professionals and receive early cognitive learning and potentially behavioral interventions. When not diagnosed early in a child’s life, FASD can give rise to secondary cognitive and behavioral disabilities.

Itti suggests that the screening tool could be implemented via a mobile unit, on an app or within pharmacies as a free screening tool for customers.

Source: University of Southern California

Leave A Reply

Your email address will not be published.